HomeProcedural SolutionsOsteoSurge® 300

OsteoSurge® 300

Our OsteoSurge® 300 grafts combine demineralized bone matrix with patented Accell® Bone Matrix in a bio-resorbable, reverse-phase medium carrier. Provided in an open-bore syringe, the putty is moldable and resists irrigation.
Key Features & Technologies

Focused on the details.

  1. Key Features
  2. Technologies
  1. Accell®
    • The patented Accell process yields Accell bone matrix (ABM). ABM is an open-structured, dispersed form of DBM. OsteoSurge 300 and OsteoSurge® 300c DBM contain the highest concentration of ABM available in our products.
  2. Superior Handling
    • The unique, poloxamer, reverse-phase medium carrier, which becomes more viscous at body temperature, provides exceptional handling and containment characteristics. The graft is moldable, packable, mixable, and resists irrigation.
  3. Verified Osteoinductive Potential
    • Every lot of DBM is tested in a validated, in vitro assay to verify osteoinductive potential.
  4. Expert Processing
    • Cortical bone and cancellous bone obtained from AATB-accredited tissue banks is processed into DBM in our state-of-the-art facility. The demineralization process is tightly controlled to consistently produce demineralized bone.
  5. Electron Beam Sterilization
    • The processing of DBM and ABM is completed under aseptic conditions in our state-of-the-art facility. As the last step in manufacturing, the graft is sterilized via electron beam irradiation.

OsteoSurge® 300 eIFUs